Barneonkologisk forskninggruppe for translasjonell forskning og avanserte terapier (TRANSLATE)

Research team members

Monica Cheng Munthe-Kaas, MD, PhD, overlege (OUS), group leader

Lars O. Baumbusch, MSc, PhD, seniorforsker (OUS) og professor II (HiØ), deputy group leader

Jochen Büchner, MD, PhD, overlege (OUS)

Heidi Glosli, MD, PhD, overlege (OUS)

Aina Ulvmoen, MD, PhD, overlege (OUS)

Anne Gro Wesenberg Rognlien, MD, PhD, overlege (OUS)

Tale Torjussen, MD, PhD, overlege (OUS)

Ingvild Heier, MD, PhD, overlege (OUS)

Ida Knapstad, MD, Overlege og PhD stipendiat (OUS)

Christina EB Opheim, MD, overlege (OUS)

Benedikte Grebstad Tune, MSc, stipendiat (OUS)

Kirsti Paulsen, MSc, stipendiat (OUS)

Weronika Przybyla, MSc, stipendiat (OUS)

Nina Robinson, Administrator Den Norske Barnekreftfbiobanken

Obse Melkamu Tesgera, Bioingeniør Den Norske Barnekreftbiobanken

Assosierte medlemmer

Finn Wesenberg, MD, PhD, prof emeritus (OUS)

Gareth Sullivan, MSc, PhD, seniorforsker (OUS)

Rønnaug Solberg, MD, PhD, forsker (OUS) og overlege (Tønsberg)

Hans Christian Erichsen, MD, PhD, overlege (OUS)

Anne Grete Bechensteen, MD, PhD, overlege (OUS)

Research goals and strategy

Will be up-dated soon.

Current research projects

Baumbusch reserach project group on childhood cancer

Main national and international collaborators

Will be up-dated soon.

Financial support

Will be up-dated soon.

Selected publications

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway.

Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D, Hjortland GO, Hovig E, Hovland R, Iversen AC, Janssen E, Kyte JA, von der Lippe Gythfeldt H, Lothe R, Lund JÅ, Meza-Zepeda L, Munthe-Kaas MC, Nguyen OTD, Niehusmann P, Nilsen H, Puco K, Ree AH, Riste TB, Semb K, Steinskog ESS, Stensvold A, Suhrke P, Tennøe Ø, Tjønnfjord GE, Vassbotn LJ, Aas E, Aasebø K, Tasken K, Smeland S. J Transl Med. 2022 May 14;20(1):225. doi: 10.1186/s12967-022-03432-5. PMID: 35568909.

Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.

Pulsipher MA, Han X, Maude SL, Laetsch TW, Qayed M, Rives S, Boyer MW, Hiramatsu H, Yanik GA, Driscoll T, Myers GD, Bader P, Baruchel A, Buechner J, Stefanski HE, Kalfoglou C, Nguyen K, Waldron ER, Thudium Mueller K, Maier HJ, Kari G, Grupp SA.Blood Cancer Discov. 2022 Jan;3(1):66-81. doi: 10.1158/2643-3230.BCD-21-0095. PMID: 35019853.

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.

Przybyła W, Gjersvoll Paulsen KM, Mishra CK, Nygård S, Engebretsen S, Ruud E, Trøen G, Beiske K, Baumbusch LO.PLoS One. 2022 Aug 29;17(8):e0273280. doi: 10.1371/journal.pone.0273280. eCollection 2022. PMID: 36037157.